๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular action of the estrogen receptor and hormone dependency in breast cancer

โœ Scribed by Hirotaka Iwase

Publisher
Springer Japan
Year
2003
Tongue
English
Weight
931 KB
Volume
10
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Functional estrogen receptors as biochem
Functional estrogen receptors as biochemical marker for the detection of hormone-dependent breast cancer
โœ Dr. U. Vij; K. Murugesan; B. M. L. Kapur; R. Sarin; I. K. Dhawan; A. Farooq ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 498 KB

The translocatable receptors categorized as functional receptors were quantitated in a cross-incubation study of breast cancer nuclei with receptor-rich uterine cytosol. Data demonstrated that tumors that contained cytosolic estrogen receptor (ER) but had translocation defect might not be hormone de

Role of estrogen receptor variants in th
Role of estrogen receptor variants in the development of hormone resistance in breast cancer
โœ Mels Sluyser ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 762 KB

Recent evidence suggests that the progression to hormone resistance in some breast tumors is due to mutations in the estrogen receptor (ER). Various types of ER variants have been found in breast cancer biopsies and breast cancer cell lines. The ER variants include dominant-positive receptors that a

Androgen receptor action in hormone-depe
Androgen receptor action in hormone-dependent and recurrent prostate cancer
โœ Irina U. Agoulnik; Nancy L. Weigel ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro

Steroid hormone receptors and coregulato
Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells
โœ Nanna Sarvilinna; Heli Eronen; Susanna Miettinen; Annika Vienonen; Timo Ylikomi ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 281 KB

## Abstract Resistance to hormonal therapy is often a problem in the treatment of breast cancer patients. It has been suggested that resistance could be explained by altered nuclear hormone receptor or coregulator levels or inappropriately increased agonist activity of selective estrogen receptor m